Home › NDC Lookup › Ingredients › Triamcinolone Acetonide › 45802-0109-01
👃image loading
(from DailyMed)

Triamcinolone Acetonide Nasal 55 ug Spray, Metered — NDC 45802-109-01 (Billing 45802-0109-01)

by Padagis Israel Pharmaceuticals Ltd · 1 BOTTLE in 1 CARTON / 120 SPRAY, METERED in 1 BOTTLE

This is a package of Triamcinolone Acetonide Nasal 55 ug Spray, Metered from Padagis Israel Pharmaceuticals Ltd, marketed since Mar 2017 and currently FDA-listed; retail pharmacies pay about $0.7388 per mL (NADAC). It is this product's only package size.

NDC 45802-0109-01
🏷️ FDA NDC (as labeled) 45802-109-01 billing pads the product segment with a zero
OTC Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Other active recalls for Triamcinolone Acetonide (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Sep 28, 2023 — Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial. (Eugia US LLC) · FDA recall D-0041-2024
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 45802-109-01
Product NDC 45802-109
11-digit billing NDC 45802010901
NCPDP billing unit ML — per mL (volume)
RxCUI 1797913
UNII F446C597KA
Application # ANDA078104
SPL Set ID 8468115a-4f0c-4ae8-bcd6-38f8b81cf871
Established class (EPC) Corticosteroid
Mechanism of action Corticosteroid Hormone Receptor Agonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2017-03-28
Route NASAL
Dosage form SPRAY, METERED
Substance TRIAMCINOLONE ACETONIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 42200060103210
GPI class Triamcinolone Acetonide
GCN Seq No 072054
GCN 36145
HICL code 002891
Ingredient (HICL) Triamcinolone Acetonide
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q7
Therapeutic class — intermediate (HIC2) Nasal Preparations
HIC3 code Q7P
Therapeutic class — specific (HIC3) Nasal Anti-Inflammatory Steroids
AHFS code 48:10.08.00
AHFS class Corticosteroids (Respiratory Tract)
FDB label name TRIAMCINOLONE 55 MCG NASAL SPR
FDB brand name Triamcinolone Acetonide
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 072054
  • GCN: 36145
  • GPI-14 (Medi-Span): 42200060103210
  • HICL (First Databank): 002891
  • AHFS class code: 48:10.08.00
  • RxCUI (RxNorm): 1797913
Why two NDCs? The FDA registers this code as 45802-109-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 45802-0109-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Corticosteroid class.

Pharmacologic class Corticosteroid
Drug family (ATC) Corticosteroids for local oral treatment, Corticosteroids, Corticosteroids, moderately potent (group II)
How it works Corticosteroid Hormone Receptor Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name TRIAMCINOLONE 55 MCG NASAL SPR Ingredient Triamcinolone Acetonide
📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Injections treat severe allergic conditions, joint inflammation, certain skin problems and eye inflammation. Creams and ointments calm itchy, inflamed sk...
  • Injections are given by a healthcare professional. Ointment is applied as a thin film to the affected area two to three times daily. Nasal spray bottles need priming before first u...
  • Possible effects include injection site pain, joint swelling, headache, muscle spasms, cough, sinusitis and bruising. People with diabetes may see higher blood sugar. Tell your doc...
  • Call right away for signs of an allergic reaction, fever or infection, a very painful and swollen joint, vision changes, or mood changes. Also report black stools, severe stomach p...
📖 Read our full Triamcinolone guide →
8
Nutrient depletion considerations

Triamcinolone Acetonide may be associated with lower levels of 8 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Triamcinolone Acetonide nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.739 —
Medicaid paysCMS SDUD · 12 mo $1.00 —
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.809 $0.716
▼ Down 2% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
45802-0109-01 You're viewing this Main listing 1 BOTTLE in 1 CARTON / 120 SPRAY, METERED in 1 BOTTLE 2017-03-28 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Good Sense Nasal Allergy 55 ug 00113-0443-01 L. 1 bottle $0.739 — Availability likely —
Nasal Allergy 55 ug 00536-1457-69 Rugby 1 bottle $0.739 — Availability likely —
Triamcinolone Acetonide Nasal 55 ugthis 45802-0109-01 Padagis 1 bottle $0.739 — Availability likely —
Good Neighbor Pharmacy 24 Hour Nasal Allergy 55 ug 46122-0385-76 Amerisource 1 bottle $0.739 — Availability likely —
Triamcinolone acetonide 55 ug 60505-6275-07 Apotex 1 bottle $0.739 — Availability likely —
Triamcinolone acetonide 55 ug 70000-0702-01 CARDINAL 1 bottle $0.739 — Discontinued —
Triamcinolone Acetonide 55 ug 70000-0742-01 CARDINAL 1 bottle $0.739 — Availability likely —
foster and thrive 24 hour nasal allergy 55 ug 70677-1023-01 Strategic 1 bottle $0.739 — Availability likely —
Allergy Nasal 55 ug 00363-0811-01 Walgreen 1 bottle — — FDA listed —
Up and Up Nasal Allergy 55 ug 11673-0717-01 Target 1 bottle — — FDA listed —
Nasal Allergy 55 ug 11822-0443-01 Rite 1 bottle — — Discontinued —
Signature Care Nasal Allergy 55 ug 21130-0443-01 Safeway 1 bottle — — FDA listed —
Nasal Allergy 55 ug 21130-0613-02 Safeway 1 bottle — — FDA listed —
Nasal Allergy Relief 55 ug 30142-0665-01 Kroger 1 bottle — — FDA listed —
nasal allergy 55 ug 30142-0813-01 Kroger 1 bottle — — FDA listed —
Topcare Nasal Allergy 55 ug 36800-0621-01 Topco 1 bottle — — FDA listed —
Nasal Allergy 55 ug 37808-0443-01 H 1 bottle — — FDA listed —
Equaline nasal allergy 55 ug 41163-0443-01 United 1 bottle — — FDA listed —
Nasacort Allergy 24HR 55 ug 41167-5800-01 Chattem, 1 bottle — — FDA listed —
24 Hour Nasal Allergy 55 ug 41250-0443-01 Meijer 1 bottle — — FDA listed —
CareOne Allergy Relief 55 ug 41520-0443-01 American 1 bottle — — Discontinued —
Equate Nasal Allergy 55 ug 49035-0443-01 Wal-Mart 1 bottle — — FDA listed —
Nasacort 55 ug 50090-1444-00 A-S 1 bottle — — FDA listed —
allergy relief 55 ug 51316-0711-01 CVS 1 bottle — — FDA listed —
DG Health Nasal Allergy 55 ug 55910-0280-02 Dolgencorp, 1 bottle — — FDA listed —
Nasal Allergy 55 ug 59779-0746-01 CVS 1 bottle — — FDA listed —
Triamcinolone acetonide 55 ug 69168-0482-01 Allegiant 1 bottle — — FDA listed —
Triamcinolone Acetonide Nasal 55 ug 72162-2289-02 Bryant 1 bottle — — FDA listed —
Basic Care Nasal Allergy 55 ug 72288-0443-01 Amazon.com 1 bottle — — FDA listed —
Nasal Allergy 55 ug 42507-0443-01 HyVee 1 bottle — — FDA listed —
Triamcinolone Acetonide 55 ug 58602-0035-07 Aurohealth 1 bottle — — FDA listed —
Childrens Triamcinolone Acetonide 55 ug 58602-0037-11 Aurohealth 1 bottle — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2017
On the market since
Mar 2017
📍
2026
Currently FDA-listed
9 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerPadagis Israel Pharmaceuticals Ltd
Application holderPERRIGO PHARMA INTERNATIONAL DAC
FDA applicationANDA078104 (ANDA)
Labeler code45802
First marketedMar 2017
Product typeHuman Otc Drug
Portfolio175 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 24 words ▾

Uses temporarily relieves these symptoms of hay fever or other upper respiratory allergies: • nasal congestion • runny nose • sneezing • itchy nose

⏱️ Dosage and Administration ~1 min read ▾

Directions Read insert (inside package) on how to: • get a new bottle ready (primed) before first use • prime bottle again if not used for more than 2 weeks • use the spray • clean the spray nozzle ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER adults and children 12 years of age and older • once daily, spray 2 times into each nostril while sniffing gently • once your allergy symptoms improve, reduce to 1 spray in each nostril per day CHILDREN 2 TO UNDER 12 YEARS OF AGE • the growth rate of some children may be slower while using this product.

Talk to your child’s doctor if your child needs to use the spray for longer than two months a year. children 6 to under 12 years of age • an adult should supervise use • once daily, spray 1 time into each nostril while sniffing gently • if allergy symptoms do not improve, increase to 2 sprays in each nostril per day. Once allergy symptoms improve, reduce to 1 spray in each nostril per day. children 2 to under 6 years of age • an adult should supervise use • once daily, spray 1 time into each nostril while sniffing gently children under 2 years of age • do not use • do not use more than directed • if you forget a dose, do not double the next dose • do not spray into eyes or mouth • if allergy symptoms do not improve after one week, stop using and talk to a doctor • do not use for the common cold • shake well before each use

⚠️ Warnings ~1 min read ▾

Warnings Do not use • in children under 2 years of age • if you have ever had an allergic reaction to any of the ingredients Ask a doctor before use if you • have had recent nose ulcers or nose surgery • have had a nose injury that has not healed • are using a steroid medicine for asthma, allergies or skin rash • have an eye infection • have or had glaucoma or cataracts When using this product • the growth rate of some children may be slower • some symptoms may get better on the first day of treatment. It may take up to one week of daily use to feel the most symptom relief. • do not share this bottle with anyone else as this may spread germs • remember to tell your doctor about all the medicines you take, including this one Stop use and ask a doctor if • you have, or come into contact with someone who has, chickenpox, measles or tuberculosis • you have or develop symptoms of an infection such as a persistent fever • you have any change in vision • you have severe or frequent nosebleeds If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📦 Storage and Handling 28 words ▾

Other information • do not use if printed bottle wrap is torn or opened • keep package and insert. They contain important information. • store between 20°-25°C (68°-77°F)

🧪 Active Ingredient 10 words ▾

Active ingredient (in each spray) Triamcinolone acetonide 55 mcg (glucocorticoid)

🧪 Inactive Ingredients 25 words ▾

Inactive ingredients benzalkonium chloride, carboxymethylcellulose sodium, dextrose anhydrous, edetate disodium dihydrate, hydrochloric acid or sodium hydroxide (for pH adjustment), microcrystalline cellulose, polysorbate 80, purified water

🎯 Purpose 4 words ▾

Purpose Allergy symptom reliever

📄 Do Not Use 25 words ▾

Do not use • in children under 2 years of age • if you have ever had an allergic reaction to any of the ingredients

📄 Ask a Doctor Before Use If 50 words ▾

Ask a doctor before use if you • have had recent nose ulcers or nose surgery • have had a nose injury that has not healed • are using a steroid medicine for asthma, allergies or skin rash • have an eye infection • have or had glaucoma or cataracts

📄 When Using This Product 71 words ▾

When using this product • the growth rate of some children may be slower • some symptoms may get better on the first day of treatment. It may take up to one week of daily use to feel the most symptom relief. • do not share this bottle with anyone else as this may spread germs • remember to tell your doctor about all the medicines you take, including this one

📄 Stop Use and Ask a Doctor If 50 words ▾

Stop use and ask a doctor if • you have, or come into contact with someone who has, chickenpox, measles or tuberculosis • you have or develop symptoms of an infection such as a persistent fever • you have any change in vision • you have severe or frequent nosebleeds

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 22 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📄 Questions or Comments 4 words ▾

Questions or comments? 1-800-719-9260

📄 Package Label / Principal Display Panel 69 words ▾

Package/Label Principal Display Panel Compare to Nasacort ® Allergy 24HR active ingredient Multi-Symptom Triamcinolone Acetonide Nasal Spray 55 mcg per spray Allergy Symptom Reliever (Glucocorticoid)* 24 Hour Relief of: • Nasal Congestion • Sneezing • Runny Nose • Itchy Nose Original Prescription Strength NON DROWSY SCENT FREE ALCOHOL FREE 120 SPRAYS *Triamcinolone acetonide is a steroid medicine known as a glucocorticoid.

0.57FL OZ (16.9 mL) Padagis ™ 443-rt-triamcinolone-acetonide-nasal-spray

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
95.5K
Units reimbursed last 4 qtrs
1.7M
Gross reimbursed last 4 qtrs
$1.69M
Avg / prescription
$17.74
Avg / unit
$1.0040
Latest quarter Q1 2026
20.9KRx
Medicaid pays / mL
$1.0040
gross reimbursed
vs
NADAC / mL
$0.7388
acquisition cost
=
Spread
+$0.2652
+36% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
40% FFS 60% MCO
Fee-for-service · 38,250 Rx Managed care · 57,241 Rx
State Medicaid map
Alaska: no data reported AK Maine: 9,937 units · 712 per 100k residents ME Washington: 49,871 units · 638 per 100k residents WA Idaho: 1,369 units · 69.7 per 100k residents ID Montana: 676 units · 59.7 per 100k residents MT North Dakota: no data reported ND Minnesota: 39,903 units · 696 per 100k residents MN Wisconsin: no data reported WI Michigan: 13,858 units · 138 per 100k residents MI New York: 216,760 units · 1,108 per 100k residents NY Vermont: 5,632 units · 870 per 100k residents VT New Hampshire: 3,346 units · 239 per 100k residents NH Oregon: 20,706 units · 489 per 100k residents OR Nevada: 28,020 units · 877 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 10,816 units · 86.2 per 100k residents IL Indiana: 20,165 units · 294 per 100k residents IN Ohio: 187,404 units · 1,590 per 100k residents OH Pennsylvania: 13,993 units · 108 per 100k residents PA New Jersey: 37,484 units · 403 per 100k residents NJ Massachusetts: 145,281 units · 2,075 per 100k residents MA California: 275,785 units · 708 per 100k residents CA Utah: no data reported UT Colorado: 43,687 units · 743 per 100k residents CO Nebraska: 4,546 units · 230 per 100k residents NE Missouri: 7,183 units · 116 per 100k residents MO Kentucky: 119,816 units · 2,647 per 100k residents KY West Virginia: no data reported WV Virginia: 39,693 units · 455 per 100k residents VA Maryland: 109,903 units · 1,778 per 100k residents MD Connecticut: 26,060 units · 720 per 100k residents CT Rhode Island: 9,008 units · 823 per 100k residents RI Arizona: 44,175 units · 594 per 100k residents AZ New Mexico: 25,547 units · 1,208 per 100k residents NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: 12,641 units · 177 per 100k residents TN North Carolina: no data reported NC South Carolina: 37,710 units · 702 per 100k residents SC Delaware: 389 units · 37.7 per 100k residents DE Oklahoma: no data reported OK Louisiana: 186 units · 4.1 per 100k residents LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 87,378 units · 792 per 100k residents GA D.C.: 4,256 units · 627 per 100k residents DC Hawaii: 4,648 units · 324 per 100k residents HI Texas: 29,138 units · 95.5 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
4.12,647
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Kentucky 2,647 /100k
2 Massachusetts 2,075 /100k
3 Maryland 1,778 /100k
4 Ohio 1,590 /100k
5 New Mexico 1,208 /100k
6 New York 1,108 /100k
7 Nevada 877 /100k
8 Vermont 870 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Triamcinolone Acetonide (matched by generic name) — the program that covers self-administered drugs. 22 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Triamcinolone Acetonide. CMS lists 5 products for this generic; we show the highest-spend one. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$17.79M
Claims incl. refills
1.7M
Beneficiaries
1.4M
Spend / beneficiary
$13.01
Spend / claim
$10.45
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Triamcinolone Acetonide Nasal (this brand).

Top reported reactions

Pruritus2,512
Rash2,412
Pain2,036
Fatigue1,939
Nausea1,851
Vomiting1,625
Diarrhoea1,604

Age at onset

Neonate11
Infant49
Child598
Adolescent456
Adult4,959
Elderly2,219

Reporter sex

0 reports
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 3,836 1,205
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 45802-0107-52 · Padagis 45802-0111-01 · Padagis →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.